Adipokines as regulators of muscle metabolism and insulin sensitivityThis paper is one of a selection of papers published in this Special Issue, entitled 14th International Biochemistry of Exercise Conference – Muscles as Molecular and Metabolic Machines, and has undergone the Journal’s usual peer review process.

Applied Physiology, Nutrition and Metabolism - Tập 34 Số 3 - Trang 396-402 - 2009
David J. Dyck1
1Department of Human Health and Nutritional Sciences, University of Guelph, Guelph, ON N1G 2W1, Canada (e-mail: ).

Tóm tắt

Skeletal muscle is the largest tissue responsible for the insulin-stimulated disposal of glucose. However, identifying the link between excess body fat and impaired insulin sensitivity in skeletal muscle has been difficult. Several adipose-derived cytokines (adipokines) have been implicated in the impairment of insulin sensitivity, while adipokines such as leptin and adiponectin exert an insulin-sensitizing effect. Leptin and adiponectin have each been shown to increase fatty acid (FA) oxidation and decrease triglyceride storage in muscle, which may explain, in part, the insulin-sensitizing effect of these cytokines. Recent evidence strongly implicates an increased localization of the FA transporters to the plasma membrane (PM) as an important factor in the accumulation of intramuscular lipids with high-fat diets and obesity. Perhaps suprisingly, relatively little attention has been paid to the ability of insulin-sensitizing compounds, such as leptin and adiponectin, to decrease the abundance of FA transporters in the PM, thereby decreasing lipid accumulation. In the case of both adipokines, there is also evidence that a resistance to their ability to stimulate FA oxidation in skeletal muscle develops during obesity. One of our recent studies indicates that this development can be very rapid (i.e., within days), and precedes the increase in lipid uptake and accumulation that leads to insulin resistance. It is noteworthy that leptin resistance can be modulated by both diet and training in rodents. Further studies examing the underlying mechanisms of the development of leptin and adiponectin resistance are warranted.

Từ khóa


Tài liệu tham khảo

Abumrad N., 1998, J. Lipid Res., 39, 2309, 10.1016/S0022-2275(20)33310-1

10.2337/diabetes.53.1.25

Ahren B., 1997, Am. J. Physiol., 273, R113

Banks W.A., 2003, Am. J. Physiol. Endocrinol. Metab., 285, E10, 10.1152/ajpendo.00468.2002

Bonen A., 1998, Am. J. Physiol., 275, E471

Bonen A., 2004, FASEB J., 18, 1144, 10.1096/fj.03-1065fje

10.2337/diabetes.54.11.3154

10.1007/s00125-004-1609-y

10.1074/jbc.M804236200

10.1210/jc.2004-1980

10.1007/s00125-004-1359-x

10.1016/j.cmet.2006.05.002

10.2337/diabetes.51.9.2727

Cortright R.N., 2000, Am. J. Physiol. Endocrinol. Metab., 278, E553, 10.1152/ajpendo.2000.278.3.E553

10.1210/jc.2004-1711

10.1007/s00125-004-1394-7

10.1111/j.1365-201X.2004.01295.x

10.1073/pnas.041591798

10.2337/diabetes.51.4.1016

10.1073/pnas.93.13.6231

10.2337/diabetes.52.9.2191

10.1152/ajpendo.00639.2006

10.1074/jbc.271.18.10697

Hulver M.W., 2003, Am. J. Physiol. Endocrinol. Metab., 284, E741, 10.1152/ajpendo.00514.2002

10.2337/diabetes.49.12.2063

10.2337/diabetes.51.7.2005

10.1007/s001250050832

Kelley D.E., 1999, Am. J. Physiol., 277, E1130, 10.1152/ajpcell.1999.277.6.C1130

10.2337/diabetes.51.10.2944

Kim J.Y., 2000, Am. J. Physiol. Endocrinol. Metab., 279, E1039, 10.1152/ajpendo.2000.279.5.E1039

10.1002/dmrr.883

Levin B.E., 2002, Am. J. Physiol. Regul. Integr. Comp. Physiol., 283, R941, 10.1152/ajpregu.00245.2002

Lin X., 1998, J. Nutr., 128, 1606, 10.1093/jn/128.10.1606

10.1038/nm0995-950

10.1074/jbc.M100052200

10.1006/bbrc.1996.0587

10.1038/nm724

10.1038/ncb1404

10.1038/415339a

10.1038/sj.ijo.0803716

10.1152/ajpendo.00545.2006

Mullen K.L., 2009, Am. J. Physiol. Regul. Integr. Comp. Physiol., 296, R243, 10.1152/ajpregu.90774.2008

10.1053/beem.2002.0223

10.2337/diabetes.46.8.1360

Nakano Y., 1996, J. Biochem., 120, 803, 10.1093/oxfordjournals.jbchem.a021483

10.1074/jbc.M311113200

10.2337/diabetes.46.6.983

Petersen K.F., 2002, J. Clin. Invest., 109, 1345, 10.1172/JCI0215001

10.2337/diabetes.49.3.431

10.1074/jbc.270.45.26746

10.1073/pnas.94.9.4637

Simoneau J.A., 1999, FASEB J., 13, 2051, 10.1096/fasebj.13.14.2051

10.1016/S0026-0495(03)00158-6

10.1113/jphysiol.2004.081679

10.1152/ajpendo.00677.2006

Steinberg G.R., 2000, Am. J. Physiol. Endocrinol. Metab., 279, E1374, 10.1152/ajpendo.2000.279.6.E1374

Steinberg G.R., 2002, Am. J. Physiol. Endocrinol. Metab., 282, E593, 10.1152/ajpendo.00303.2001

10.1074/jbc.M107683200

Steinberg G.R., 2002, Am. J. Physiol. Endocrinol. Metab., 283, E187, 10.1152/ajpendo.00542.2001

Steinberg G.R., 2003, Am. J. Physiol. Endocrinol. Metab., 284, E648, 10.1152/ajpendo.00318.2002

10.1152/ajpendo.00302.2003

10.1210/jc.2006-0638

10.2337/diabetes.53.5.1215

Summers S.A., 1998, Mol. Cell. Biol., 18, 5457, 10.1128/MCB.18.9.5457

10.1016/S0898-6568(02)00006-2

Thrush A.B., 2008, Am. J. Physiol. Regul. Integr. Comp. Physiol., 294, R1205, 10.1152/ajpregu.00909.2007

10.1073/pnas.222657499

10.1074/jbc.M402367200

10.2337/diabetes.50.6.1389

10.2337/db07-0093

10.1172/JCI119171

10.1152/ajpendo.00464.2003

10.1210/en.2004-1096

10.2337/diabetes.50.12.2786

10.1038/90984

10.1038/nm788

10.1074/jbc.M209033200

10.1016/j.lfs.2003.08.037

10.2337/db05-1322

10.1074/jbc.M200958200

10.1073/pnas.94.12.6386

Thông tin
Thông tin xuất bản

Applied Physiology, Nutrition and Metabolism

Tập 34 Số 3

396-402

Thông tin tác giả